Scientists identify key regulator of male fertility

September 19, 2017

CINCINNATI - When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.

Researchers at Cincinnati Children's Hospital Medical Center report in Genes & Development identifying the key molecular and genetic switch that activates production of healthy male sperm -- but only when the time is right.

The mechanism is a protein complex called Polycomb Repressive Complex 1 (PRC1). Researchers were surprised when they found that PRC1 activates specific germline genes and the production of healthy sperm.

This is because when male mammals such as humans and mice are born, they come with all the reproductive germline cells (including inheritable genetics) needed to help make healthy fertile sperm and offspring. But the sperm isn't fertile during infancy or childhood. True to the "repressive" in its name, PRC1 also tamps down specific genes and the activation of fertile sperm production until an individual reaches reproductive age.

Researchers show in their current study that when mice reach reproductive age, the PRC1 protein complex changes. It sheds reproductive germline gene components that block fertile sperm production and substitutes in a component (Sall4) that start spermatogenesis -- the production of fertile sperm.

"A long-standing question has been how reproductive germline genes are activated in a precise and timely manner. Our study answers this fundamental question by identifying novel epigenetic machinery that directs timely activation of spermatogenesis," said Satoshi Namekawa, PhD, lead study investigator and member of the Division of Reproductive Sciences in the Cincinnati Children's Perinatal Institute. "This has a very high impact because we found that this repressor of sperm production, PRC1, has a new function by promoting gene activation to make sperm when the time comes."

The scientists also found that when PRC1 is disrupted, such as in male mice bred to not express PRC1, the animals have smaller testes and are unable to produce healthy sperm or offspring. Researchers still need to find out precisely how or why PRC1 changes its role from sperm suppressor to activator.

Intriguing Future Questions

The current study opens the door to asking intriguing new questions about how lifestyle or other environmental factors might affect a male's reproductive capabilities through epigenetics -- or how environmental factors can turn genes on or off in the body, Namekawa said. The findings also provide an opportunity to determine whether PRC1 or one of its genetic/molecular partners (like Sall4) can be useful as clinical biomarkers for male infertility.

Raising the stakes for these answering these questions, Namekawa and other researchers have learned that disruptions or epigenetic changes to an individual's reproductive germline cells can be passed on to subsequent generations of offspring.
Funding support for the study came from the March of Dimes 531 Foundation (grant FY13-510) and the National Institutes of Health (DP2GM119134, R01GM098605).

Cincinnati Children's Hospital Medical Center

Related Male Infertility Articles from Brightsurf:

Delivering proteins to testes could someday treat male infertility
According to the Mayo Clinic, about 15% of couples are infertile, and male infertility plays a role in over one-third of these cases.

A critical enzyme for sperm formation could be a target for treating male infertility
Researchers led by Jeremy Wang of the University of Pennsylvania School of Veterinary Medicine have identified an enzyme essential for the process of male meiosis, the type of cell division that produces sperm.

Discovery of genes involved in infertility
A research group from Kumamoto University, Japan has discovered a gene, 'Meiosin', that acts as the switch to turn on meiosis.

Trial examines effect of folic acid, zinc supplementation in male partners of couples seeking infertility treatment
This randomized clinical trial examined the effects of daily folic acid and zinc supplementation in men on semen quality and live births among 2,300 couples planning infertility treatment.

New gene for male infertility discovered
Investigators have found that a genetic rearrangement and variants affecting a gene known as SYCP2 are associated with low sperm count and report the first cases implicating the gene in four men with infertility.

Penn researchers uncover defective sperm epigenome that leads to male infertility
One out of eight couples has trouble conceiving, with a quarter of those cases caused by unexplained male infertility.

A potential new way to diagnose male infertility and pharmaceutical treatment options
Washington State University-led research has discovered infertile men have identifiable patterns of epigenetic molecules or biomarkers attached to their sperm DNA that aren't present in fertile men.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

ICSI has no outcome benefits over conventional IVF in routine non-male infertility cases
Intracytoplasmic sperm injection (ICSI), the world's favored means of fertilization in assisted reproduction, offers no benefit over conventional in vitro fertilization in fertility treatments without a male factor indication, according to results of a large multicenter study.

The FASEB Journal: DNA repair gene linked to male infertility
A key DNA repair gene known as X-ray repair cross-complementing group 1, or XRCC1, plays a vital role in maintaining genomic stability and is highly expressed in the early stages of sperm cell development (also known as spermatogenesis).

Read More: Male Infertility News and Male Infertility Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to